CL2008002602A1 - Metodo para identificar un compuesto de prueba que modula la interaccion de dos proteinas de interes, donde una de ellas esta unida a una proteasa, la que activa a una proteina activadora de reportero, que se encuentra reordenada y unida a la otra proteina, al producirse la interaccion de las proteinas de interés; kit para ensayo. - Google Patents

Metodo para identificar un compuesto de prueba que modula la interaccion de dos proteinas de interes, donde una de ellas esta unida a una proteasa, la que activa a una proteina activadora de reportero, que se encuentra reordenada y unida a la otra proteina, al producirse la interaccion de las proteinas de interés; kit para ensayo.

Info

Publication number
CL2008002602A1
CL2008002602A1 CL2008002602A CL2008002602A CL2008002602A1 CL 2008002602 A1 CL2008002602 A1 CL 2008002602A1 CL 2008002602 A CL2008002602 A CL 2008002602A CL 2008002602 A CL2008002602 A CL 2008002602A CL 2008002602 A1 CL2008002602 A1 CL 2008002602A1
Authority
CL
Chile
Prior art keywords
protein
activates
proteins
interest
interaction
Prior art date
Application number
CL2008002602A
Other languages
English (en)
Spanish (es)
Inventor
Paul S Wright
Paul Weissensee
Haifeng Eishingdrelo
Jidong Cai
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CL2008002602A1 publication Critical patent/CL2008002602A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL2008002602A 2007-09-04 2008-09-02 Metodo para identificar un compuesto de prueba que modula la interaccion de dos proteinas de interes, donde una de ellas esta unida a una proteasa, la que activa a una proteina activadora de reportero, que se encuentra reordenada y unida a la otra proteina, al producirse la interaccion de las proteinas de interés; kit para ensayo. CL2008002602A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96975607P 2007-09-04 2007-09-04
US8498708P 2008-07-30 2008-07-30

Publications (1)

Publication Number Publication Date
CL2008002602A1 true CL2008002602A1 (es) 2009-06-05

Family

ID=40029329

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002602A CL2008002602A1 (es) 2007-09-04 2008-09-02 Metodo para identificar un compuesto de prueba que modula la interaccion de dos proteinas de interes, donde una de ellas esta unida a una proteasa, la que activa a una proteina activadora de reportero, que se encuentra reordenada y unida a la otra proteina, al producirse la interaccion de las proteinas de interés; kit para ensayo.

Country Status (21)

Country Link
US (2) US8574865B2 (https=)
EP (1) EP2191275B1 (https=)
JP (1) JP5618829B2 (https=)
KR (1) KR101636306B1 (https=)
CN (1) CN102187225B (https=)
AU (1) AU2008296501B2 (https=)
BR (1) BRPI0816289B1 (https=)
CA (1) CA2698362C (https=)
CL (1) CL2008002602A1 (https=)
CY (1) CY1113816T1 (https=)
DK (1) DK2191275T3 (https=)
ES (1) ES2393642T3 (https=)
IL (1) IL204260A (https=)
MX (1) MX2010002399A (https=)
MY (1) MY155343A (https=)
PL (1) PL2191275T3 (https=)
PT (1) PT2191275E (https=)
RU (1) RU2476891C2 (https=)
TW (1) TWI425094B (https=)
UY (1) UY31323A1 (https=)
WO (1) WO2009032716A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009032716A1 (en) * 2007-09-04 2009-03-12 Sanofi-Aventis Identifying molecules that modulate protein- protein interactions using protease activated reporters
WO2014196932A1 (en) * 2013-06-06 2014-12-11 Agency For Science, Technology And Research Protease-responsive peptide biosensors and methods for analyte detection
CA2930001A1 (en) 2013-11-11 2015-05-14 University Hospitals Cleveland Medical Center Targeted treatment of anerobic cancer
CN107003323B (zh) 2014-11-25 2019-06-04 文塔纳医疗系统公司 使用化学连接和半抗原转移的邻近测定法
WO2016153880A2 (en) * 2015-03-23 2016-09-29 The Regents Of The University Of California Methods for detection of rnase activity
RU2639539C2 (ru) * 2015-12-29 2017-12-21 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Репортерная система на основе лентивирусных репортерных конструкций для изучения белок-белковых взаимодействий
US20180301048A1 (en) * 2017-04-12 2018-10-18 Age Of Learning, Inc. Remote live tutoring platform
WO2020028381A1 (en) * 2018-07-30 2020-02-06 Montana Molecular, Llc Biosensors for detecting arrestin signaling
JP2022513606A (ja) * 2018-12-10 2022-02-09 イエール ユニバーシティ 宿主の生理機能を形成する微生物叢代謝産物
JP2022551820A (ja) * 2019-10-15 2022-12-14 エフ．ホフマン－ラ ロシュ アーゲー 細胞内または小胞内生体分子相互作用を検出するための人工膜貫通タンパク質
WO2022259904A1 (ja) * 2021-06-07 2022-12-15 国立研究開発法人理化学研究所 プロテアーゼ活性測定用の融合タンパク質基質

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US5891646A (en) 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US7128915B2 (en) 1997-09-18 2006-10-31 Research Development Foundation Membrane virus host range mutations and their uses as vaccine substrates
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
US20030157553A1 (en) 2000-03-03 2003-08-21 Gabriel Berstein Methods of assaying for G protein-coupled receptor ligands and modulators
EP1205191A1 (en) 2000-11-13 2002-05-15 Centre National De La Recherche Scientifique Targeted modification of intracellular compounds
EP1353182A3 (en) 2002-04-12 2004-02-04 Smithkline Beecham Corporation Method of predicting cell-based assay results using binding profiles
US20070224615A1 (en) * 2003-07-09 2007-09-27 Invitrogen Corporation Methods for assaying protein-protein interactions
JP4734498B2 (ja) * 2003-07-09 2011-07-27 ライフ テクノロジーズ コーポレイション タンパク質−タンパク質相互作用を解析する方法
US7524925B2 (en) 2004-11-18 2009-04-28 Washington State University Protein interaction reporter agents and methods for using same
WO2009032716A1 (en) * 2007-09-04 2009-03-12 Sanofi-Aventis Identifying molecules that modulate protein- protein interactions using protease activated reporters
EP3508570B1 (en) * 2010-05-11 2020-07-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics

Also Published As

Publication number Publication date
WO2009032716A1 (en) 2009-03-12
US20100311096A1 (en) 2010-12-09
PL2191275T3 (pl) 2013-01-31
JP5618829B2 (ja) 2014-11-05
CY1113816T1 (el) 2016-07-27
DK2191275T3 (da) 2012-11-26
MY155343A (en) 2015-10-15
AU2008296501B2 (en) 2014-07-03
JP2010537669A (ja) 2010-12-09
BRPI0816289A2 (pt) 2016-11-01
CN102187225A (zh) 2011-09-14
US8574865B2 (en) 2013-11-05
IL204260A (en) 2013-12-31
KR20100058526A (ko) 2010-06-03
TW200925281A (en) 2009-06-16
KR101636306B1 (ko) 2016-07-05
CA2698362C (en) 2013-03-26
AU2008296501A1 (en) 2009-03-12
HK1162664A1 (zh) 2012-08-31
UY31323A1 (es) 2009-04-30
MX2010002399A (es) 2010-03-25
PT2191275E (pt) 2012-11-16
TWI425094B (zh) 2014-02-01
US20140162289A1 (en) 2014-06-12
RU2010112854A (ru) 2011-10-10
RU2476891C2 (ru) 2013-02-27
EP2191275B1 (en) 2012-08-08
CN102187225B (zh) 2015-08-05
ES2393642T3 (es) 2012-12-26
EP2191275A1 (en) 2010-06-02
BRPI0816289B1 (pt) 2019-01-15
BRPI0816289A8 (pt) 2018-05-08
WO2009032716A8 (en) 2011-02-17
CA2698362A1 (en) 2009-03-12
US9023610B2 (en) 2015-05-05

Similar Documents

Publication Publication Date Title
CL2008002602A1 (es) Metodo para identificar un compuesto de prueba que modula la interaccion de dos proteinas de interes, donde una de ellas esta unida a una proteasa, la que activa a una proteina activadora de reportero, que se encuentra reordenada y unida a la otra proteina, al producirse la interaccion de las proteinas de interés; kit para ensayo.
CO6680656A2 (es) Anticuerpos para metaloproteinasa -9 de matriz
HN2008001104A (es) Compuestos para anticuerpos de dickpf-1 y70-4
GT200500226A (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
UY33366A (es) FIBRONECTINA TIPO III A LA DÉCIMA (10Fn3) DE UNIÓN A SEROALBÚMINA Y MOLÉCULAS DE FUSIÓN QUE LAS COMPRENDE
GT200900038A (es) Compuestos y metodos para inhibir la interaccion de las proteinas bcl con agentes aglutinantes
BR112014021081A2 (pt) anticorpos para a metaloproteinase da matriz 9
MX2007004342A (es) Moleculas cop1 y uso de las mismas.
CO6602147A2 (es) Uso de combinado de proteínas cry1ca y cry1fa para el manejo de la resistencia de insectos
BR112012014773A2 (pt) esponja de compósito hemostática, método para fabricar uma esponja de compósito hemostática, e, uso da referida esponja
ES2674177T3 (es) Preparación de suero
MX2011009242A (es) Metodo y material para el acomplejamiento activado en el sitio de moleculas biologicas.
CL2013003090A1 (es) Polipeptido que comprende una primera secuencia de aminoacidos que comprende a su vez al menos un dominio variable individual de inmunoglobulina que se enlaza especificamente a il-17f, il17-a/f, pero no a il-17a, y una segunda secuencia de aminoacidos que comprende a su vez al menos un dominio variable individual de inmunoglobulina que se enlaza especificamente a il-17a, il-17f y il17-a/f; composicion farmaceutica que lo comprende; y su uso.
GT200900256A (es) 3-imidazolil-indoles para el tratamiento de las enfermedades proliferativas
HN2008000346A (es) Secuencias de nucleotidos que codifican proteinas insecticidas
CR9869A (es) Compuestos activos en ppar
EP2507267A4 (en) COMPOSITIONS AND METHODS FOR INCREASING THE SERUM DURABILITY OF FC FUSION PROTEINS
CR11282A (es) Proteinas enlazadas al antigeno de celula de cepa mcdonough de felino humanas
GT200900035A (es) Anticuerpo especifico prlr y sus usos
WO2008021484A3 (en) Assay system to identify therapeutic agents
CL2011000206A1 (es) Composicion biocida que comprende ciprodinil y fluazinam; metodo para controlar enfermedades, en plantas utiles o en material de propagacion, causadas por fitopatogenos (div. sol. n°2602-06).
BRPI0803089A2 (pt) ensaio de proteìnas
CL2009001488A1 (es) Metodo para tratar una muestra liquida que contiene particulas microbiologicas.
AR091836A1 (es) Metodo para purificar el factor transgenico vii
BR112013000840A2 (pt) método para aumentar o efeito de forma ativada potencializada de anticorpo para molécula endógena biológica, composição farmacêutica e uso de combinação de molécula biológica endógena com forma ativada potencializada de anticorpo para a sintase no endotelial.